Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG4BY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $86,939
Award facts
- Contract value 100% obligated
- $86,938.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $86,938.77 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections on February 3, 2026, with completion scheduled for February 4, 2026. This firm fixed-price, non-set-aside contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion vehicle that extends through December 2031. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with performance occurring at its corporate office location in Conshohocken.
This delivery order supports the military's pharmaceutical supply chain by procuring Zepbound, a GLP-1 receptor agonist primarily used for weight management, which reflects the expanding scope of medications provided through the DLA Medical Supply Chain to support Defense Health Agency beneficiaries and other federal healthcare systems. The award demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements through open competition, consistent with its established portfolio of delivering specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FG4BY?
SPE2DR26FG4BY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26FG4BY worth?
The government has obligated $86,939 on SPE2DR26FG4BY.
Is contract SPE2DR26FG4BY an order under another contract?
Yes. SPE2DR26FG4BY is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG4BY competed?
The extent of competition for SPE2DR26FG4BY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award